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The aims of this thesis were to (i) examine how studying resilience factors could be 
beneficial for deepening our understanding of trauma susceptibility, and (ii) gain insights 
into epigenetic underpinnings of post-traumatic stress disorder (PTSD) and start 
exploring whether some of these could potentially serve as diagnostic biomarkers for 
PTSD. In order to answer these questions, this thesis presented two literature reviews, 
three experimental studies and one methodological chapter. 
 
First, the available literature on resilience studies was summarized in a review presented 
in Chapter 2. This overview highlights the need to standardize resilience studies, starting 
with the way resilience is currently being defined. Studying factors that could promote 
resilience, either through cognitive strategies or pharmacologically by targeting 
biological pathways of resilience, if and when identified once study designs are optimal, 
will be beneficial for at-risk individuals. This is further emphasized by the fact that 
addressing potential mental health issues is currently not always receiving sufficient 
attention within the military. 
 
In order to get a first understanding of what is known regarding the implications of 
microRNAs (miRNAs) in PTSD, a second review was presented in Chapter 3. By being 
easily accessible and relatively stable in biofluids and across species, miRNAs hold the 
exciting potential to serve as biomarkers of disease. In the context of PTSD, most of the 
work has been done in animals by modeling traumatic stress and studying associated 
phenotypes, while most human research examined trauma-related miRNAs in military 
populations. These studies are mostly characterized by small sample sizes and a great 
variety in the way miRNAs are being analyzed. Although informative as a first exploration 
of miRNA dysregulations in PTSD, we suggest that future studies use longitudinal designs 
by incorporating time points prior to and following stress exposure in order to gain 
insights into the role of circulating miRNAs in the onset and course of PTSD. When 
possible, combining such studies with animal studies would be of added value in order 
to track corresponding molecular mechanisms occurring within the brain which could 
potentially yield novel avenues for treatment strategies. 
 
Next, several experimental studies were performed using blood samples from deployed 
military members. In Chapter 4 we performed a first pilot study in order to examine 
circulating miRNA profiles of deployed military members with or without PTSD. 
Expression profiles of several miRNAs were found to be dysregulated between individuals 
with PTSD, trauma-exposed controls and healthy controls, some of which had previously 
been associated with PTSD. Although preliminary, this study highlights the feasibility and 
 
 
potential usefulness of clustering miRNAs based on their expression profiles and use this 
information to distinguish individuals with PTSD from (trauma-exposed) healthy controls. 
 
This study gave rise to several questions, one of which included whether exosomal 
miRNAs would be better suited for sampling and analysis given the higher stability of 
encapsulated miRNAs and the potential that these vesicles offer to track their tissue of 
origin. The protocol needed to isolate and analyze exosomal miRNAs within plasma 
neuron-derived exosomes (NDEs), i.e. exosomes released by neurons which end up in 
the blood circulation, was presented in Chapter 5. This methodological chapter provides 
insights into the workflow needed to capture these vesicles and sequence their miRNA 
content. 
 
In Chapter 6, we then applied this knowledge to plasma samples belonging to 
individuals with PTSD, along with urine samples from the same individuals, and serum 
samples from an independent cohort of PTSD subjects. This study is the first to assess 
the miRNA content of NDEs present in limited amounts of several human biofluids using 
high-throughput sequencing. The findings generated by this pilot study indicate several 
aspects. First, it is feasible to sequence the miRNA content of NDEs using small amounts 
of human plasma. Next, two specific miRNAs could potentially, if replicated in larger 
cohorts, serve as markers for PTSD, especially given the interesting fact that both were 
expressed in all samples of PTSD subjects, while being absent in all (but one) of the 
control samples. More research is needed in order to assess whether urine can be used 
for these analyses, for example by assessing the precise origin of L1CAM+ exosomes 
present in urine. Finally, our findings suggest that older serum samples might still be 
useful for NDE miRNA analyses, although the stability of these miRNAs should be 
assessed further given the potentially considerable degradation of larger RNA fragments. 
 
Finally, in Chapter 7 we took a different approach of looking at epigenetic mechanisms 
in PTSD and focused on DNA methylation by performing one of the first studies that 
used longitudinal measures of DNA methylation. We combined DNA methylation data 
from three military cohorts from which blood methylation and phenotypic information 
was collected prior to and following combat exposure. Our findings highlight several 
differentially methylated positions and regions, some of which had previously been 
associated with PTSD, thereby enhancing their potential implication in the disorder. 
 
 
